![Foto de Andrés](/img/nophoto.png)
Andrés
Íñiguez Romo
Publicaciones en las que colabora con Andrés Íñiguez Romo (20)
2023
-
Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial
International Journal of Cardiology, Vol. 391
-
Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530
2021
-
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433
2020
-
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention
European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770
-
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2018
-
Alirocumab and cardiovascular outcomes after acute coronary syndrome
New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107
-
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
International Journal of Cardiology, Vol. 254, pp. 10-15
-
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835
2017
-
ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy
Basic and Clinical Pharmacology and Toxicology, Vol. 120, Núm. 5, pp. 466-474
-
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 176-185
-
Evolocumab and clinical outcomes in patients with cardiovascular disease
New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722
2016
-
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists
British Journal of Haematology, Vol. 174, Núm. 4, pp. 610-623
-
On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013
Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 551-553
2015
-
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation
Circulation: Cardiovascular Quality and Outcomes, Vol. 8, pp. S12-S20
-
Post-introduction observation of transcatheter aortic valve implantation in Galicia (Spain)
Journal of Evaluation in Clinical Practice, Vol. 21, Núm. 1, pp. 34-42
2013
-
Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients
Clinica Chimica Acta, Vol. 425, pp. 9-17
2012
-
Increased clopidogrel response is associated with ABCC3 expression: A pilot study
Clinica Chimica Acta, Vol. 413, Núm. 3-4, pp. 417-421
2011
-
Modelo de intervención coronaria percutánea primaria en la Comunidad de Galicia
Revista Espanola de Cardiologia Suplementos, Vol. 11, Núm. SUPPL. 3, pp. 44-50
-
Modelo de intervención coronaria percutánea primaria en la Comunidad de Galicia
Revista Espanola de Cardiologia Suplementos, Vol. 11, Núm. 3, pp. 44-50